首页> 外文期刊>Schizophrenia research >A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia
【24h】

A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia

机译:精神分裂症患者每月一次帕潘立酮棕榈酸酯与每日口服抗精神病药物治疗的实用性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Persons with schizophrenia often come in contact with the criminal justice system (CJS). This analysis of subjects with schizophrenia and a history of contact with the CJS estimated and compared mean cumulative function (MCF) of treatment failure events when treated with paliperidone palmitate (PP) or oral antipsychotics (OAs). All events identified during the full study period of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) trial were evaluated.
机译:背景:精神分裂症患者通常会与刑事司法系统(CJS)接触。这项对精神分裂症患者和与CJS接触史的分析分析估计并比较了帕潘立酮棕榈酸酯(PP)或口服抗精神病药(OAs)治疗失败事件的平均累积功能(MCF)。评估了帕潘立酮棕榈酸酯研究有效性研究(PRIDE)试验在整个研究期间发现的所有事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号